Modern pharmacological research shows that AR treatment ameliorated the severity of DN by inhibiting inflammation-related gene IL-1β and IL-18 expression and fibrosis indexes in DN rats [12]. The gene discussed is IL1B; the disease is liver dysplastic nodule.